Go Back

Domain Associates

Domain Associates, a venture fund established in 1985, specializes in investing in life sciences companies at various stages from Pre-Seed to Series D. Based in San Diego, California, the fund is led by Partner Brian Halak. With a focus on BioTech, Medical Device, and Pharmaceuticals, Domain Associates has invested in 303 companies and has seen 90 successful exits. One of their portfolio companies is Axial Biotherapeutics. For more information, visit their website at www.domainvc.com.

About

About

About

Bio

Domain Associates is a venture capital firm with an exclusive focus on life sciences.

Location

San Diego, California

Stage

Pre-Seed, Seed, Series A, Series B, Series C, Series D

Partner name

Brian Halak

Bio

Domain Associates is a venture capital firm with an exclusive focus on life sciences.

Location

San Diego, California

Stage

Pre-Seed, Seed, Series A, Series B, Series C, Series D

Partner name

Brian Halak

Fund

Fund

Fund

Fund Focus

BioTech, Medical Device, Pharmaceuticals

Number of investments

303

Number of exits

90

Fund Type

Venture Fund

Portfolio Companies

Axial Biotherapeutics

Domain Associates

Domain Associates, a venture fund established in 1985, specializes in investing in life sciences companies at various stages from Pre-Seed to Series D. Based in San Diego, California, the fund is led by Partner Brian Halak. With a focus on BioTech, Medical Device, and Pharmaceuticals, Domain Associates has invested in 303 companies and has seen 90 successful exits. One of their portfolio companies is Axial Biotherapeutics. For more information, visit their website at www.domainvc.com.

About

Bio

Domain Associates is a venture capital firm with an exclusive focus on life sciences.

Location

San Diego, California

Stage

Pre-Seed, Seed, Series A, Series B, Series C, Series D

Partner name

Brian Halak

Fund

Fund Focus

BioTech, Medical Device, Pharmaceuticals

Number of investments

303

Number of exits

90

Fund Type

Venture Fund

Portfolio Companies

Axial Biotherapeutics